Mar 04 2025 58 mins
Conversation w/ Doug Elwood, MD, MBA, Chief Medical Officer, and Mark Hanson, PhD, Adviser, Sunday Health, about the interrelationship between biomarkers and artificial intelligence, and other promising diagnostic tools and therapies, which enhance early detection and personalized treatment strategies for MCI and mild dementia.